nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—CYP3A4—Everolimus—kidney cancer	0.0658	0.103	CbGbCtD
Fosphenytoin—CYP2C8—Pazopanib—kidney cancer	0.0576	0.0903	CbGbCtD
Fosphenytoin—ALB—Erlotinib—kidney cancer	0.0532	0.0833	CbGbCtD
Fosphenytoin—CYP3A4—Temsirolimus—kidney cancer	0.0445	0.0697	CbGbCtD
Fosphenytoin—CYP2B6—Sorafenib—kidney cancer	0.0441	0.0691	CbGbCtD
Fosphenytoin—CYP2C9—Capecitabine—kidney cancer	0.0419	0.0657	CbGbCtD
Fosphenytoin—CYP2C8—Erlotinib—kidney cancer	0.0411	0.0644	CbGbCtD
Fosphenytoin—CYP2C8—Paclitaxel—kidney cancer	0.0376	0.059	CbGbCtD
Fosphenytoin—CYP2C8—Sorafenib—kidney cancer	0.0334	0.0524	CbGbCtD
Fosphenytoin—CYP2C19—Sorafenib—kidney cancer	0.028	0.0439	CbGbCtD
Fosphenytoin—CYP2B6—Doxorubicin—kidney cancer	0.0268	0.0419	CbGbCtD
Fosphenytoin—CYP2C9—Paclitaxel—kidney cancer	0.0262	0.0411	CbGbCtD
Fosphenytoin—CYP3A4—Pazopanib—kidney cancer	0.0234	0.0366	CbGbCtD
Fosphenytoin—CYP2C9—Sorafenib—kidney cancer	0.0233	0.0365	CbGbCtD
Fosphenytoin—CYP3A4—Erlotinib—kidney cancer	0.0167	0.0261	CbGbCtD
Fosphenytoin—CYP3A4—Paclitaxel—kidney cancer	0.0153	0.0239	CbGbCtD
Fosphenytoin—CYP3A4—Sorafenib—kidney cancer	0.0135	0.0212	CbGbCtD
Fosphenytoin—CYP3A4—Vinblastine—kidney cancer	0.0134	0.021	CbGbCtD
Fosphenytoin—CYP3A4—Vincristine—kidney cancer	0.0132	0.0206	CbGbCtD
Fosphenytoin—CYP3A4—Sunitinib—kidney cancer	0.011	0.0172	CbGbCtD
Fosphenytoin—CYP3A4—Doxorubicin—kidney cancer	0.00822	0.0129	CbGbCtD
Fosphenytoin—Phenylbutazone—PTGS1—kidney cancer	0.000279	0.524	CrCbGaD
Fosphenytoin—Pharyngitis—Capecitabine—kidney cancer	0.000182	0.000564	CcSEcCtD
Fosphenytoin—Insomnia—Vincristine—kidney cancer	0.000181	0.00056	CcSEcCtD
Fosphenytoin—Anorexia—Gemcitabine—kidney cancer	0.000181	0.00056	CcSEcCtD
Fosphenytoin—Vomiting—Vinblastine—kidney cancer	0.00018	0.000559	CcSEcCtD
Fosphenytoin—Dizziness—Erlotinib—kidney cancer	0.00018	0.000559	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Paclitaxel—kidney cancer	0.00018	0.000559	CcSEcCtD
Fosphenytoin—Vomiting—Everolimus—kidney cancer	0.00018	0.000557	CcSEcCtD
Fosphenytoin—Anaemia—Paclitaxel—kidney cancer	0.00018	0.000557	CcSEcCtD
Fosphenytoin—Paraesthesia—Vincristine—kidney cancer	0.000179	0.000556	CcSEcCtD
Fosphenytoin—Agitation—Paclitaxel—kidney cancer	0.000179	0.000554	CcSEcCtD
Fosphenytoin—Rash—Everolimus—kidney cancer	0.000178	0.000553	CcSEcCtD
Fosphenytoin—Dermatitis—Everolimus—kidney cancer	0.000178	0.000552	CcSEcCtD
Fosphenytoin—Headache—Vinblastine—kidney cancer	0.000178	0.000551	CcSEcCtD
Fosphenytoin—Headache—Everolimus—kidney cancer	0.000177	0.000549	CcSEcCtD
Fosphenytoin—Hypotension—Gemcitabine—kidney cancer	0.000177	0.000549	CcSEcCtD
Fosphenytoin—Body temperature increased—Dactinomycin—kidney cancer	0.000177	0.000548	CcSEcCtD
Fosphenytoin—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000176	0.000547	CcSEcCtD
Fosphenytoin—Asthenia—Sorafenib—kidney cancer	0.000176	0.000546	CcSEcCtD
Fosphenytoin—Malaise—Paclitaxel—kidney cancer	0.000175	0.000544	CcSEcCtD
Fosphenytoin—Vertigo—Paclitaxel—kidney cancer	0.000175	0.000541	CcSEcCtD
Fosphenytoin—Syncope—Paclitaxel—kidney cancer	0.000174	0.00054	CcSEcCtD
Fosphenytoin—Leukopenia—Paclitaxel—kidney cancer	0.000174	0.000539	CcSEcCtD
Fosphenytoin—Decreased appetite—Vincristine—kidney cancer	0.000174	0.000538	CcSEcCtD
Fosphenytoin—Pruritus—Sorafenib—kidney cancer	0.000174	0.000538	CcSEcCtD
Fosphenytoin—Vomiting—Erlotinib—kidney cancer	0.000173	0.000538	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000173	0.000535	CcSEcCtD
Fosphenytoin—Rash—Erlotinib—kidney cancer	0.000172	0.000533	CcSEcCtD
Fosphenytoin—Dermatitis—Erlotinib—kidney cancer	0.000172	0.000533	CcSEcCtD
Fosphenytoin—Palpitations—Paclitaxel—kidney cancer	0.000172	0.000533	CcSEcCtD
Fosphenytoin—Insomnia—Gemcitabine—kidney cancer	0.000171	0.000531	CcSEcCtD
Fosphenytoin—Headache—Erlotinib—kidney cancer	0.000171	0.00053	CcSEcCtD
Fosphenytoin—Tinnitus—Capecitabine—kidney cancer	0.000171	0.00053	CcSEcCtD
Fosphenytoin—Loss of consciousness—Paclitaxel—kidney cancer	0.000171	0.00053	CcSEcCtD
Fosphenytoin—Constipation—Vincristine—kidney cancer	0.000171	0.00053	CcSEcCtD
Fosphenytoin—Diplopia—Doxorubicin—kidney cancer	0.000171	0.000529	CcSEcCtD
Fosphenytoin—Osteoarthritis—Doxorubicin—kidney cancer	0.000171	0.000529	CcSEcCtD
Fosphenytoin—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000171	0.000529	CcSEcCtD
Fosphenytoin—Paraesthesia—Gemcitabine—kidney cancer	0.00017	0.000528	CcSEcCtD
Fosphenytoin—Cough—Paclitaxel—kidney cancer	0.00017	0.000526	CcSEcCtD
Fosphenytoin—Asthenia—Sunitinib—kidney cancer	0.000169	0.000525	CcSEcCtD
Fosphenytoin—Dyspnoea—Gemcitabine—kidney cancer	0.000169	0.000524	CcSEcCtD
Fosphenytoin—Nausea—Vinblastine—kidney cancer	0.000168	0.000523	CcSEcCtD
Fosphenytoin—Somnolence—Gemcitabine—kidney cancer	0.000168	0.000522	CcSEcCtD
Fosphenytoin—Convulsion—Paclitaxel—kidney cancer	0.000168	0.000522	CcSEcCtD
Fosphenytoin—Migraine—Doxorubicin—kidney cancer	0.000168	0.000521	CcSEcCtD
Fosphenytoin—Affect lability—Doxorubicin—kidney cancer	0.000168	0.000521	CcSEcCtD
Fosphenytoin—Nausea—Everolimus—kidney cancer	0.000168	0.000521	CcSEcCtD
Fosphenytoin—Diarrhoea—Sorafenib—kidney cancer	0.000168	0.000521	CcSEcCtD
Fosphenytoin—Hypertension—Paclitaxel—kidney cancer	0.000168	0.00052	CcSEcCtD
Fosphenytoin—Pruritus—Sunitinib—kidney cancer	0.000167	0.000518	CcSEcCtD
Fosphenytoin—Arthralgia—Paclitaxel—kidney cancer	0.000165	0.000513	CcSEcCtD
Fosphenytoin—Myalgia—Paclitaxel—kidney cancer	0.000165	0.000513	CcSEcCtD
Fosphenytoin—Face oedema—Doxorubicin—kidney cancer	0.000165	0.000511	CcSEcCtD
Fosphenytoin—Decreased appetite—Gemcitabine—kidney cancer	0.000165	0.000511	CcSEcCtD
Fosphenytoin—Chills—Capecitabine—kidney cancer	0.000164	0.00051	CcSEcCtD
Fosphenytoin—Discomfort—Paclitaxel—kidney cancer	0.000163	0.000507	CcSEcCtD
Fosphenytoin—Cardiac arrest—Doxorubicin—kidney cancer	0.000162	0.000503	CcSEcCtD
Fosphenytoin—Dizziness—Sorafenib—kidney cancer	0.000162	0.000503	CcSEcCtD
Fosphenytoin—Constipation—Gemcitabine—kidney cancer	0.000162	0.000502	CcSEcCtD
Fosphenytoin—Nausea—Erlotinib—kidney cancer	0.000162	0.000502	CcSEcCtD
Fosphenytoin—Dry mouth—Paclitaxel—kidney cancer	0.000162	0.000502	CcSEcCtD
Fosphenytoin—Mood swings—Doxorubicin—kidney cancer	0.000162	0.000502	CcSEcCtD
Fosphenytoin—Diarrhoea—Sunitinib—kidney cancer	0.000161	0.000501	CcSEcCtD
Fosphenytoin—Ataxia—Doxorubicin—kidney cancer	0.00016	0.000498	CcSEcCtD
Fosphenytoin—Asthenia—Dactinomycin—kidney cancer	0.00016	0.000497	CcSEcCtD
Fosphenytoin—Confusional state—Paclitaxel—kidney cancer	0.00016	0.000496	CcSEcCtD
Fosphenytoin—Phenylbutazone—PTGS2—kidney cancer	0.00016	0.299	CrCbGaD
Fosphenytoin—Dehydration—Doxorubicin—kidney cancer	0.000159	0.000492	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Paclitaxel—kidney cancer	0.000159	0.000492	CcSEcCtD
Fosphenytoin—Body temperature increased—Vincristine—kidney cancer	0.000158	0.00049	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Doxorubicin—kidney cancer	0.000158	0.000489	CcSEcCtD
Fosphenytoin—Infection—Paclitaxel—kidney cancer	0.000158	0.000489	CcSEcCtD
Fosphenytoin—Flatulence—Capecitabine—kidney cancer	0.000157	0.000487	CcSEcCtD
Fosphenytoin—Dysgeusia—Capecitabine—kidney cancer	0.000156	0.000484	CcSEcCtD
Fosphenytoin—Dizziness—Sunitinib—kidney cancer	0.000156	0.000484	CcSEcCtD
Fosphenytoin—Feeling abnormal—Gemcitabine—kidney cancer	0.000156	0.000484	CcSEcCtD
Fosphenytoin—Shock—Paclitaxel—kidney cancer	0.000156	0.000484	CcSEcCtD
Fosphenytoin—Vomiting—Sorafenib—kidney cancer	0.000156	0.000484	CcSEcCtD
Fosphenytoin—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000156	0.000484	CcSEcCtD
Fosphenytoin—Hypokalaemia—Doxorubicin—kidney cancer	0.000155	0.000482	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Paclitaxel—kidney cancer	0.000155	0.000482	CcSEcCtD
Fosphenytoin—Tachycardia—Paclitaxel—kidney cancer	0.000155	0.00048	CcSEcCtD
Fosphenytoin—Rash—Sorafenib—kidney cancer	0.000155	0.00048	CcSEcCtD
Fosphenytoin—Dermatitis—Sorafenib—kidney cancer	0.000155	0.000479	CcSEcCtD
Fosphenytoin—Back pain—Capecitabine—kidney cancer	0.000154	0.000478	CcSEcCtD
Fosphenytoin—Headache—Sorafenib—kidney cancer	0.000154	0.000477	CcSEcCtD
Fosphenytoin—Muscle spasms—Capecitabine—kidney cancer	0.000153	0.000476	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Paclitaxel—kidney cancer	0.000153	0.000476	CcSEcCtD
Fosphenytoin—Diarrhoea—Dactinomycin—kidney cancer	0.000153	0.000474	CcSEcCtD
Fosphenytoin—Anorexia—Paclitaxel—kidney cancer	0.000151	0.000469	CcSEcCtD
Fosphenytoin—Gastritis—Doxorubicin—kidney cancer	0.000151	0.000469	CcSEcCtD
Fosphenytoin—Muscular weakness—Doxorubicin—kidney cancer	0.000151	0.000467	CcSEcCtD
Fosphenytoin—Vomiting—Sunitinib—kidney cancer	0.00015	0.000466	CcSEcCtD
Fosphenytoin—Body temperature increased—Gemcitabine—kidney cancer	0.00015	0.000464	CcSEcCtD
Fosphenytoin—Tremor—Capecitabine—kidney cancer	0.000149	0.000463	CcSEcCtD
Fosphenytoin—Rash—Sunitinib—kidney cancer	0.000149	0.000462	CcSEcCtD
Fosphenytoin—Dermatitis—Sunitinib—kidney cancer	0.000149	0.000461	CcSEcCtD
Fosphenytoin—Hypotension—Paclitaxel—kidney cancer	0.000148	0.00046	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Capecitabine—kidney cancer	0.000148	0.000459	CcSEcCtD
Fosphenytoin—Headache—Sunitinib—kidney cancer	0.000148	0.000459	CcSEcCtD
Fosphenytoin—Influenza—Doxorubicin—kidney cancer	0.000147	0.000458	CcSEcCtD
Fosphenytoin—Asthma—Doxorubicin—kidney cancer	0.000147	0.000458	CcSEcCtD
Fosphenytoin—Dysphagia—Doxorubicin—kidney cancer	0.000147	0.000458	CcSEcCtD
Fosphenytoin—Anaemia—Capecitabine—kidney cancer	0.000147	0.000457	CcSEcCtD
Fosphenytoin—Nausea—Sorafenib—kidney cancer	0.000146	0.000452	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000144	0.000448	CcSEcCtD
Fosphenytoin—Malaise—Capecitabine—kidney cancer	0.000144	0.000446	CcSEcCtD
Fosphenytoin—Insomnia—Paclitaxel—kidney cancer	0.000143	0.000445	CcSEcCtD
Fosphenytoin—Vertigo—Capecitabine—kidney cancer	0.000143	0.000444	CcSEcCtD
Fosphenytoin—Asthenia—Vincristine—kidney cancer	0.000143	0.000444	CcSEcCtD
Fosphenytoin—Syncope—Capecitabine—kidney cancer	0.000143	0.000444	CcSEcCtD
Fosphenytoin—Leukopenia—Capecitabine—kidney cancer	0.000143	0.000443	CcSEcCtD
Fosphenytoin—Paraesthesia—Paclitaxel—kidney cancer	0.000142	0.000442	CcSEcCtD
Fosphenytoin—Vomiting—Dactinomycin—kidney cancer	0.000142	0.000441	CcSEcCtD
Fosphenytoin—Bronchitis—Doxorubicin—kidney cancer	0.000142	0.00044	CcSEcCtD
Fosphenytoin—Dyspnoea—Paclitaxel—kidney cancer	0.000141	0.000439	CcSEcCtD
Fosphenytoin—Somnolence—Paclitaxel—kidney cancer	0.000141	0.000437	CcSEcCtD
Fosphenytoin—Palpitations—Capecitabine—kidney cancer	0.000141	0.000437	CcSEcCtD
Fosphenytoin—Rash—Dactinomycin—kidney cancer	0.000141	0.000437	CcSEcCtD
Fosphenytoin—Nausea—Sunitinib—kidney cancer	0.00014	0.000435	CcSEcCtD
Fosphenytoin—Loss of consciousness—Capecitabine—kidney cancer	0.00014	0.000435	CcSEcCtD
Fosphenytoin—Dyspepsia—Paclitaxel—kidney cancer	0.00014	0.000433	CcSEcCtD
Fosphenytoin—Cough—Capecitabine—kidney cancer	0.000139	0.000432	CcSEcCtD
Fosphenytoin—Dysuria—Doxorubicin—kidney cancer	0.000138	0.000428	CcSEcCtD
Fosphenytoin—Decreased appetite—Paclitaxel—kidney cancer	0.000138	0.000428	CcSEcCtD
Fosphenytoin—Hypertension—Capecitabine—kidney cancer	0.000138	0.000427	CcSEcCtD
Fosphenytoin—Diarrhoea—Vincristine—kidney cancer	0.000137	0.000424	CcSEcCtD
Fosphenytoin—Asthenia—Gemcitabine—kidney cancer	0.000136	0.000422	CcSEcCtD
Fosphenytoin—Arthralgia—Capecitabine—kidney cancer	0.000136	0.000421	CcSEcCtD
Fosphenytoin—Myalgia—Capecitabine—kidney cancer	0.000136	0.000421	CcSEcCtD
Fosphenytoin—Constipation—Paclitaxel—kidney cancer	0.000136	0.000421	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000135	0.000418	CcSEcCtD
Fosphenytoin—Discomfort—Capecitabine—kidney cancer	0.000134	0.000416	CcSEcCtD
Fosphenytoin—Pruritus—Gemcitabine—kidney cancer	0.000134	0.000416	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Doxorubicin—kidney cancer	0.000133	0.000413	CcSEcCtD
Fosphenytoin—Dry mouth—Capecitabine—kidney cancer	0.000133	0.000412	CcSEcCtD
Fosphenytoin—Nausea—Dactinomycin—kidney cancer	0.000133	0.000412	CcSEcCtD
Fosphenytoin—Pneumonia—Doxorubicin—kidney cancer	0.000132	0.00041	CcSEcCtD
Fosphenytoin—Dizziness—Vincristine—kidney cancer	0.000132	0.00041	CcSEcCtD
Fosphenytoin—Confusional state—Capecitabine—kidney cancer	0.000131	0.000407	CcSEcCtD
Fosphenytoin—Feeling abnormal—Paclitaxel—kidney cancer	0.000131	0.000405	CcSEcCtD
Fosphenytoin—Diarrhoea—Gemcitabine—kidney cancer	0.00013	0.000402	CcSEcCtD
Fosphenytoin—Renal failure—Doxorubicin—kidney cancer	0.000129	0.000401	CcSEcCtD
Fosphenytoin—Infection—Capecitabine—kidney cancer	0.000129	0.000401	CcSEcCtD
Fosphenytoin—Shock—Capecitabine—kidney cancer	0.000128	0.000397	CcSEcCtD
Fosphenytoin—Conjunctivitis—Doxorubicin—kidney cancer	0.000128	0.000397	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Capecitabine—kidney cancer	0.000127	0.000395	CcSEcCtD
Fosphenytoin—Tachycardia—Capecitabine—kidney cancer	0.000127	0.000394	CcSEcCtD
Fosphenytoin—Vomiting—Vincristine—kidney cancer	0.000127	0.000394	CcSEcCtD
Fosphenytoin—Sweating—Doxorubicin—kidney cancer	0.000126	0.000391	CcSEcCtD
Fosphenytoin—Urticaria—Paclitaxel—kidney cancer	0.000126	0.000391	CcSEcCtD
Fosphenytoin—Rash—Vincristine—kidney cancer	0.000126	0.00039	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Capecitabine—kidney cancer	0.000126	0.00039	CcSEcCtD
Fosphenytoin—Dermatitis—Vincristine—kidney cancer	0.000126	0.00039	CcSEcCtD
Fosphenytoin—Body temperature increased—Paclitaxel—kidney cancer	0.000125	0.000389	CcSEcCtD
Fosphenytoin—Headache—Vincristine—kidney cancer	0.000125	0.000388	CcSEcCtD
Fosphenytoin—Epistaxis—Doxorubicin—kidney cancer	0.000124	0.000385	CcSEcCtD
Fosphenytoin—Anorexia—Capecitabine—kidney cancer	0.000124	0.000385	CcSEcCtD
Fosphenytoin—Sinusitis—Doxorubicin—kidney cancer	0.000123	0.000383	CcSEcCtD
Fosphenytoin—Hypotension—Capecitabine—kidney cancer	0.000122	0.000377	CcSEcCtD
Fosphenytoin—Vomiting—Gemcitabine—kidney cancer	0.00012	0.000374	CcSEcCtD
Fosphenytoin—Bradycardia—Doxorubicin—kidney cancer	0.00012	0.000373	CcSEcCtD
Fosphenytoin—Rash—Gemcitabine—kidney cancer	0.000119	0.00037	CcSEcCtD
Fosphenytoin—Dermatitis—Gemcitabine—kidney cancer	0.000119	0.00037	CcSEcCtD
Fosphenytoin—Headache—Gemcitabine—kidney cancer	0.000119	0.000368	CcSEcCtD
Fosphenytoin—Nausea—Vincristine—kidney cancer	0.000119	0.000368	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000119	0.000368	CcSEcCtD
Fosphenytoin—Rhinitis—Doxorubicin—kidney cancer	0.000118	0.000367	CcSEcCtD
Fosphenytoin—Insomnia—Capecitabine—kidney cancer	0.000118	0.000365	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Doxorubicin—kidney cancer	0.000117	0.000364	CcSEcCtD
Fosphenytoin—Pharyngitis—Doxorubicin—kidney cancer	0.000117	0.000363	CcSEcCtD
Fosphenytoin—Paraesthesia—Capecitabine—kidney cancer	0.000117	0.000362	CcSEcCtD
Fosphenytoin—Dyspnoea—Capecitabine—kidney cancer	0.000116	0.00036	CcSEcCtD
Fosphenytoin—Dyspepsia—Capecitabine—kidney cancer	0.000115	0.000355	CcSEcCtD
Fosphenytoin—Asthenia—Paclitaxel—kidney cancer	0.000114	0.000353	CcSEcCtD
Fosphenytoin—Decreased appetite—Capecitabine—kidney cancer	0.000113	0.000351	CcSEcCtD
Fosphenytoin—Nausea—Gemcitabine—kidney cancer	0.000112	0.000349	CcSEcCtD
Fosphenytoin—Pruritus—Paclitaxel—kidney cancer	0.000112	0.000348	CcSEcCtD
Fosphenytoin—Constipation—Capecitabine—kidney cancer	0.000111	0.000345	CcSEcCtD
Fosphenytoin—Tinnitus—Doxorubicin—kidney cancer	0.00011	0.000341	CcSEcCtD
Fosphenytoin—Diarrhoea—Paclitaxel—kidney cancer	0.000108	0.000337	CcSEcCtD
Fosphenytoin—Feeling abnormal—Capecitabine—kidney cancer	0.000107	0.000333	CcSEcCtD
Fosphenytoin—Chills—Doxorubicin—kidney cancer	0.000106	0.000329	CcSEcCtD
Fosphenytoin—Dizziness—Paclitaxel—kidney cancer	0.000105	0.000325	CcSEcCtD
Fosphenytoin—Urticaria—Capecitabine—kidney cancer	0.000103	0.000321	CcSEcCtD
Fosphenytoin—Body temperature increased—Capecitabine—kidney cancer	0.000103	0.000319	CcSEcCtD
Fosphenytoin—Flatulence—Doxorubicin—kidney cancer	0.000101	0.000314	CcSEcCtD
Fosphenytoin—Tension—Doxorubicin—kidney cancer	0.000101	0.000313	CcSEcCtD
Fosphenytoin—Vomiting—Paclitaxel—kidney cancer	0.000101	0.000313	CcSEcCtD
Fosphenytoin—Dysgeusia—Doxorubicin—kidney cancer	0.000101	0.000312	CcSEcCtD
Fosphenytoin—Rash—Paclitaxel—kidney cancer	0.0001	0.00031	CcSEcCtD
Fosphenytoin—Dermatitis—Paclitaxel—kidney cancer	9.99e-05	0.00031	CcSEcCtD
Fosphenytoin—Nervousness—Doxorubicin—kidney cancer	9.98e-05	0.00031	CcSEcCtD
Fosphenytoin—Back pain—Doxorubicin—kidney cancer	9.94e-05	0.000308	CcSEcCtD
Fosphenytoin—Headache—Paclitaxel—kidney cancer	9.93e-05	0.000308	CcSEcCtD
Fosphenytoin—Muscle spasms—Doxorubicin—kidney cancer	9.88e-05	0.000307	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Doxorubicin—kidney cancer	9.54e-05	0.000296	CcSEcCtD
Fosphenytoin—Anaemia—Doxorubicin—kidney cancer	9.5e-05	0.000295	CcSEcCtD
Fosphenytoin—Agitation—Doxorubicin—kidney cancer	9.44e-05	0.000293	CcSEcCtD
Fosphenytoin—Phenytoin—ABCB1—kidney cancer	9.43e-05	0.177	CrCbGaD
Fosphenytoin—Nausea—Paclitaxel—kidney cancer	9.42e-05	0.000292	CcSEcCtD
Fosphenytoin—Asthenia—Capecitabine—kidney cancer	9.34e-05	0.00029	CcSEcCtD
Fosphenytoin—Malaise—Doxorubicin—kidney cancer	9.27e-05	0.000288	CcSEcCtD
Fosphenytoin—Vertigo—Doxorubicin—kidney cancer	9.23e-05	0.000286	CcSEcCtD
Fosphenytoin—Syncope—Doxorubicin—kidney cancer	9.22e-05	0.000286	CcSEcCtD
Fosphenytoin—Pruritus—Capecitabine—kidney cancer	9.21e-05	0.000286	CcSEcCtD
Fosphenytoin—Leukopenia—Doxorubicin—kidney cancer	9.2e-05	0.000285	CcSEcCtD
Fosphenytoin—Palpitations—Doxorubicin—kidney cancer	9.08e-05	0.000282	CcSEcCtD
Fosphenytoin—Loss of consciousness—Doxorubicin—kidney cancer	9.03e-05	0.00028	CcSEcCtD
Fosphenytoin—Cough—Doxorubicin—kidney cancer	8.97e-05	0.000278	CcSEcCtD
Fosphenytoin—Convulsion—Doxorubicin—kidney cancer	8.9e-05	0.000276	CcSEcCtD
Fosphenytoin—Diarrhoea—Capecitabine—kidney cancer	8.9e-05	0.000276	CcSEcCtD
Fosphenytoin—Hypertension—Doxorubicin—kidney cancer	8.87e-05	0.000275	CcSEcCtD
Fosphenytoin—Arthralgia—Doxorubicin—kidney cancer	8.75e-05	0.000271	CcSEcCtD
Fosphenytoin—Myalgia—Doxorubicin—kidney cancer	8.75e-05	0.000271	CcSEcCtD
Fosphenytoin—Discomfort—Doxorubicin—kidney cancer	8.64e-05	0.000268	CcSEcCtD
Fosphenytoin—Dizziness—Capecitabine—kidney cancer	8.6e-05	0.000267	CcSEcCtD
Fosphenytoin—Dry mouth—Doxorubicin—kidney cancer	8.56e-05	0.000265	CcSEcCtD
Fosphenytoin—Confusional state—Doxorubicin—kidney cancer	8.46e-05	0.000262	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Doxorubicin—kidney cancer	8.39e-05	0.00026	CcSEcCtD
Fosphenytoin—Infection—Doxorubicin—kidney cancer	8.33e-05	0.000258	CcSEcCtD
Fosphenytoin—Vomiting—Capecitabine—kidney cancer	8.27e-05	0.000257	CcSEcCtD
Fosphenytoin—Shock—Doxorubicin—kidney cancer	8.25e-05	0.000256	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Doxorubicin—kidney cancer	8.21e-05	0.000255	CcSEcCtD
Fosphenytoin—Rash—Capecitabine—kidney cancer	8.2e-05	0.000255	CcSEcCtD
Fosphenytoin—Dermatitis—Capecitabine—kidney cancer	8.2e-05	0.000254	CcSEcCtD
Fosphenytoin—Tachycardia—Doxorubicin—kidney cancer	8.19e-05	0.000254	CcSEcCtD
Fosphenytoin—Headache—Capecitabine—kidney cancer	8.15e-05	0.000253	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Doxorubicin—kidney cancer	8.11e-05	0.000252	CcSEcCtD
Fosphenytoin—Anorexia—Doxorubicin—kidney cancer	8e-05	0.000248	CcSEcCtD
Fosphenytoin—Hypotension—Doxorubicin—kidney cancer	7.84e-05	0.000243	CcSEcCtD
Fosphenytoin—Nausea—Capecitabine—kidney cancer	7.73e-05	0.00024	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	7.64e-05	0.000237	CcSEcCtD
Fosphenytoin—Insomnia—Doxorubicin—kidney cancer	7.59e-05	0.000235	CcSEcCtD
Fosphenytoin—Paraesthesia—Doxorubicin—kidney cancer	7.53e-05	0.000234	CcSEcCtD
Fosphenytoin—Dyspnoea—Doxorubicin—kidney cancer	7.48e-05	0.000232	CcSEcCtD
Fosphenytoin—Somnolence—Doxorubicin—kidney cancer	7.46e-05	0.000231	CcSEcCtD
Fosphenytoin—Dyspepsia—Doxorubicin—kidney cancer	7.38e-05	0.000229	CcSEcCtD
Fosphenytoin—Decreased appetite—Doxorubicin—kidney cancer	7.29e-05	0.000226	CcSEcCtD
Fosphenytoin—Constipation—Doxorubicin—kidney cancer	7.17e-05	0.000223	CcSEcCtD
Fosphenytoin—Feeling abnormal—Doxorubicin—kidney cancer	6.91e-05	0.000214	CcSEcCtD
Fosphenytoin—Urticaria—Doxorubicin—kidney cancer	6.66e-05	0.000207	CcSEcCtD
Fosphenytoin—Body temperature increased—Doxorubicin—kidney cancer	6.63e-05	0.000206	CcSEcCtD
Fosphenytoin—Asthenia—Doxorubicin—kidney cancer	6.02e-05	0.000187	CcSEcCtD
Fosphenytoin—Pruritus—Doxorubicin—kidney cancer	5.93e-05	0.000184	CcSEcCtD
Fosphenytoin—Diarrhoea—Doxorubicin—kidney cancer	5.74e-05	0.000178	CcSEcCtD
Fosphenytoin—Dizziness—Doxorubicin—kidney cancer	5.55e-05	0.000172	CcSEcCtD
Fosphenytoin—Vomiting—Doxorubicin—kidney cancer	5.33e-05	0.000165	CcSEcCtD
Fosphenytoin—Rash—Doxorubicin—kidney cancer	5.29e-05	0.000164	CcSEcCtD
Fosphenytoin—Dermatitis—Doxorubicin—kidney cancer	5.28e-05	0.000164	CcSEcCtD
Fosphenytoin—Headache—Doxorubicin—kidney cancer	5.25e-05	0.000163	CcSEcCtD
Fosphenytoin—Nausea—Doxorubicin—kidney cancer	4.98e-05	0.000155	CcSEcCtD
Fosphenytoin—CYP2C9—Metabolism—PDHB—kidney cancer	2.85e-05	0.000728	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.85e-05	0.000727	CbGpPWpGaD
Fosphenytoin—CYP2C9—Biological oxidations—POMC—kidney cancer	2.84e-05	0.000726	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GLIPR1—kidney cancer	2.84e-05	0.000725	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PPAT—kidney cancer	2.84e-05	0.000725	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—CTNNB1—kidney cancer	2.83e-05	0.000722	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.82e-05	0.00072	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.8e-05	0.000716	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ALAD—kidney cancer	2.8e-05	0.000714	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.79e-05	0.000713	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.78e-05	0.000709	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ST3GAL2—kidney cancer	2.73e-05	0.000697	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CCBL1—kidney cancer	2.68e-05	0.000685	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ALDH1A1—kidney cancer	2.67e-05	0.000681	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.66e-05	0.000679	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—APRT—kidney cancer	2.66e-05	0.000678	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—FH—kidney cancer	2.66e-05	0.000678	CbGpPWpGaD
Fosphenytoin—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.65e-05	0.000677	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—FH—kidney cancer	2.64e-05	0.000674	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—APRT—kidney cancer	2.64e-05	0.000674	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—IFNA1—kidney cancer	2.62e-05	0.000669	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.62e-05	0.000668	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.6e-05	0.000663	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.58e-05	0.000659	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PGK1—kidney cancer	2.56e-05	0.000653	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—SLC5A3—kidney cancer	2.56e-05	0.000653	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PPAT—kidney cancer	2.55e-05	0.000651	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GLIPR1—kidney cancer	2.55e-05	0.000651	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.52e-05	0.000643	CbGpPWpGaD
Fosphenytoin—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.51e-05	0.000642	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—LDHB—kidney cancer	2.51e-05	0.00064	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GPC3—kidney cancer	2.5e-05	0.000638	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.49e-05	0.000636	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—VEGFA—kidney cancer	2.49e-05	0.000635	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GPC3—kidney cancer	2.48e-05	0.000634	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.48e-05	0.000633	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—IFNA2—kidney cancer	2.44e-05	0.000623	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CA2—kidney cancer	2.43e-05	0.00062	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.42e-05	0.000619	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.42e-05	0.000619	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CA2—kidney cancer	2.42e-05	0.000617	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—FH—kidney cancer	2.37e-05	0.000605	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—APRT—kidney cancer	2.37e-05	0.000605	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ALAD—kidney cancer	2.37e-05	0.000604	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ALAD—kidney cancer	2.35e-05	0.000601	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—MAPK3—kidney cancer	2.35e-05	0.000601	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	2.34e-05	0.000598	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.34e-05	0.000598	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GLIPR1—kidney cancer	2.32e-05	0.000594	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PPAT—kidney cancer	2.32e-05	0.000594	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.32e-05	0.000592	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ST3GAL2—kidney cancer	2.31e-05	0.00059	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ST3GAL2—kidney cancer	2.3e-05	0.000587	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.3e-05	0.000586	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.27e-05	0.00058	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ALDH1A1—kidney cancer	2.26e-05	0.000577	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ALDH1A1—kidney cancer	2.25e-05	0.000573	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—MAPK1—kidney cancer	2.24e-05	0.000572	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GPC3—kidney cancer	2.23e-05	0.000569	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ACY1—kidney cancer	2.21e-05	0.000565	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—IGF2—kidney cancer	2.19e-05	0.000561	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CA9—kidney cancer	2.17e-05	0.000555	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CA2—kidney cancer	2.17e-05	0.000554	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PGK1—kidney cancer	2.16e-05	0.000553	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—SLC5A3—kidney cancer	2.16e-05	0.000553	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—APRT—kidney cancer	2.16e-05	0.000552	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—FH—kidney cancer	2.16e-05	0.000552	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—SLC5A3—kidney cancer	2.15e-05	0.00055	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PGK1—kidney cancer	2.15e-05	0.00055	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—LDHB—kidney cancer	2.12e-05	0.000542	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—KRAS—kidney cancer	2.11e-05	0.00054	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ALAD—kidney cancer	2.11e-05	0.00054	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.11e-05	0.000539	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—LDHB—kidney cancer	2.11e-05	0.000539	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	2.1e-05	0.000537	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ST3GAL2—kidney cancer	2.06e-05	0.000527	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GPC3—kidney cancer	2.03e-05	0.000519	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ALDH1A1—kidney cancer	2.02e-05	0.000515	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CA2—kidney cancer	1.98e-05	0.000505	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PGK1—kidney cancer	1.93e-05	0.000493	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.93e-05	0.000493	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ALAD—kidney cancer	1.93e-05	0.000492	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—LDHB—kidney cancer	1.89e-05	0.000484	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PDHB—kidney cancer	1.88e-05	0.00048	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.88e-05	0.00048	CbGpPWpGaD
Fosphenytoin—CYP3A4—Biological oxidations—POMC—kidney cancer	1.87e-05	0.000479	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CRABP1—kidney cancer	1.85e-05	0.000472	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.85e-05	0.000472	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CA9—kidney cancer	1.84e-05	0.00047	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.84e-05	0.000469	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CA9—kidney cancer	1.83e-05	0.000467	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.8e-05	0.000459	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.79e-05	0.000457	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	1.79e-05	0.000456	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CCBL1—kidney cancer	1.77e-05	0.000452	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PGK1—kidney cancer	1.76e-05	0.00045	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.76e-05	0.00045	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—LDHB—kidney cancer	1.73e-05	0.000441	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ITPR2—kidney cancer	1.72e-05	0.000439	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	1.69e-05	0.000431	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CA9—kidney cancer	1.64e-05	0.00042	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	1.61e-05	0.00041	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.61e-05	0.00041	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTT1—kidney cancer	1.57e-05	0.0004	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ACHE—kidney cancer	1.57e-05	0.0004	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CRABP1—kidney cancer	1.57e-05	0.0004	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CRABP1—kidney cancer	1.56e-05	0.000397	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.53e-05	0.000392	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PPAT—kidney cancer	1.53e-05	0.000392	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CA9—kidney cancer	1.5e-05	0.000383	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—SCARB1—kidney cancer	1.48e-05	0.000379	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PTGS1—kidney cancer	1.47e-05	0.000375	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.46e-05	0.000374	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ITPR2—kidney cancer	1.46e-05	0.000372	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ITPR2—kidney cancer	1.45e-05	0.000369	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PSMD7—kidney cancer	1.44e-05	0.000368	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—FH—kidney cancer	1.43e-05	0.000364	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—APRT—kidney cancer	1.43e-05	0.000364	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CRABP1—kidney cancer	1.4e-05	0.000357	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	1.39e-05	0.000356	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—BCHE—kidney cancer	1.37e-05	0.000349	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—SLC5A5—kidney cancer	1.35e-05	0.000344	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.34e-05	0.000343	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GPC3—kidney cancer	1.34e-05	0.000342	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.33e-05	0.000341	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ACHE—kidney cancer	1.33e-05	0.000339	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTT1—kidney cancer	1.33e-05	0.000339	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTT1—kidney cancer	1.32e-05	0.000337	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ACHE—kidney cancer	1.32e-05	0.000337	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CA2—kidney cancer	1.3e-05	0.000333	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—SLC2A1—kidney cancer	1.3e-05	0.000333	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ITPR2—kidney cancer	1.3e-05	0.000332	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CRABP1—kidney cancer	1.27e-05	0.000325	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ALAD—kidney cancer	1.27e-05	0.000324	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—SCARB1—kidney cancer	1.26e-05	0.000321	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—SCARB1—kidney cancer	1.25e-05	0.000319	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PTGS1—kidney cancer	1.24e-05	0.000318	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.24e-05	0.000317	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PTGS1—kidney cancer	1.24e-05	0.000316	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PSMD7—kidney cancer	1.22e-05	0.000311	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PSMD7—kidney cancer	1.21e-05	0.00031	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.21e-05	0.00031	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—RAF1—kidney cancer	1.21e-05	0.000308	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.2e-05	0.000306	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ACHE—kidney cancer	1.18e-05	0.000302	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTT1—kidney cancer	1.18e-05	0.000302	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ITPR2—kidney cancer	1.18e-05	0.000302	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.16e-05	0.000297	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PGK1—kidney cancer	1.16e-05	0.000297	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—BCHE—kidney cancer	1.16e-05	0.000295	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—BCHE—kidney cancer	1.15e-05	0.000294	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—SLC5A5—kidney cancer	1.14e-05	0.000292	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—LDHB—kidney cancer	1.14e-05	0.000291	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—SLC5A5—kidney cancer	1.14e-05	0.00029	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—SCARB1—kidney cancer	1.12e-05	0.000286	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PTGS1—kidney cancer	1.11e-05	0.000283	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—SLC2A1—kidney cancer	1.1e-05	0.000282	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—SLC2A1—kidney cancer	1.1e-05	0.00028	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.09e-05	0.000279	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PSMD7—kidney cancer	1.09e-05	0.000278	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTP1—kidney cancer	1.09e-05	0.000277	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—IL2—kidney cancer	1.08e-05	0.000277	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ACHE—kidney cancer	1.08e-05	0.000276	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTT1—kidney cancer	1.08e-05	0.000276	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.07e-05	0.000273	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.06e-05	0.000272	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	1.05e-05	0.000267	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—BCHE—kidney cancer	1.03e-05	0.000263	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ABCB1—kidney cancer	1.03e-05	0.000263	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—SCARB1—kidney cancer	1.02e-05	0.000261	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—SLC5A5—kidney cancer	1.02e-05	0.00026	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PTGS1—kidney cancer	1.01e-05	0.000258	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTM1—kidney cancer	9.98e-06	0.000255	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PSMD7—kidney cancer	9.92e-06	0.000253	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CA9—kidney cancer	9.88e-06	0.000252	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—SLC2A1—kidney cancer	9.84e-06	0.000251	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.55e-06	0.000244	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CYP1A1—kidney cancer	9.46e-06	0.000242	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—BCHE—kidney cancer	9.41e-06	0.00024	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.33e-06	0.000238	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—SLC5A5—kidney cancer	9.29e-06	0.000237	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.28e-06	0.000237	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—VEGFA—kidney cancer	9.2e-06	0.000235	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTP1—kidney cancer	9.2e-06	0.000235	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTP1—kidney cancer	9.15e-06	0.000234	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—SLC2A1—kidney cancer	8.97e-06	0.000229	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.71e-06	0.000222	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—MAPK3—kidney cancer	8.71e-06	0.000222	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ABCB1—kidney cancer	8.71e-06	0.000222	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ABCB1—kidney cancer	8.66e-06	0.000221	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTM1—kidney cancer	8.45e-06	0.000216	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTM1—kidney cancer	8.4e-06	0.000215	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CRABP1—kidney cancer	8.4e-06	0.000215	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.33e-06	0.000213	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—MAPK1—kidney cancer	8.28e-06	0.000212	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTP1—kidney cancer	8.21e-06	0.00021	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYP1A1—kidney cancer	8.01e-06	0.000205	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYP1A1—kidney cancer	7.97e-06	0.000203	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—KRAS—kidney cancer	7.83e-06	0.0002	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ITPR2—kidney cancer	7.81e-06	0.000199	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ABCB1—kidney cancer	7.77e-06	0.000198	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.59e-06	0.000194	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTM1—kidney cancer	7.54e-06	0.000193	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTP1—kidney cancer	7.49e-06	0.000191	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PIK3CA—kidney cancer	7.19e-06	0.000184	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP1A1—kidney cancer	7.15e-06	0.000183	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTT1—kidney cancer	7.12e-06	0.000182	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ACHE—kidney cancer	7.12e-06	0.000182	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ABCB1—kidney cancer	7.09e-06	0.000181	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—POMC—kidney cancer	7.06e-06	0.00018	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—TP53—kidney cancer	6.95e-06	0.000178	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTM1—kidney cancer	6.88e-06	0.000176	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SCARB1—kidney cancer	6.74e-06	0.000172	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PTGS1—kidney cancer	6.67e-06	0.00017	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.58e-06	0.000168	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.55e-06	0.000167	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PSMD7—kidney cancer	6.54e-06	0.000167	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP1A1—kidney cancer	6.52e-06	0.000167	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—BCHE—kidney cancer	6.2e-06	0.000158	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SLC5A5—kidney cancer	6.13e-06	0.000157	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—POMC—kidney cancer	5.97e-06	0.000153	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—POMC—kidney cancer	5.94e-06	0.000152	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SLC2A1—kidney cancer	5.92e-06	0.000151	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.88e-06	0.00015	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PTGS2—kidney cancer	5.63e-06	0.000144	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.36e-06	0.000137	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—POMC—kidney cancer	5.33e-06	0.000136	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTP1—kidney cancer	4.94e-06	0.000126	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PTEN—kidney cancer	4.91e-06	0.000125	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—POMC—kidney cancer	4.86e-06	0.000124	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PTGS2—kidney cancer	4.76e-06	0.000122	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PTGS2—kidney cancer	4.74e-06	0.000121	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ABCB1—kidney cancer	4.67e-06	0.000119	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTM1—kidney cancer	4.54e-06	0.000116	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP1A1—kidney cancer	4.3e-06	0.00011	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PTGS2—kidney cancer	4.25e-06	0.000109	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PTEN—kidney cancer	4.16e-06	0.000106	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PTEN—kidney cancer	4.13e-06	0.000106	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PTGS2—kidney cancer	3.88e-06	9.9e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PTEN—kidney cancer	3.71e-06	9.47e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CA—kidney cancer	3.46e-06	8.84e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PTEN—kidney cancer	3.38e-06	8.64e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—POMC—kidney cancer	3.21e-06	8.19e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.93e-06	7.49e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CA—kidney cancer	2.91e-06	7.44e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CA—kidney cancer	2.62e-06	6.68e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PTGS2—kidney cancer	2.56e-06	6.53e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CA—kidney cancer	2.39e-06	6.09e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PTEN—kidney cancer	2.23e-06	5.7e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.57e-06	4.02e-05	CbGpPWpGaD
